| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Arcutis Biotherapeutics, Inc. | SVP Chief Financial Officer | Common Stock | 64.9K | $1.6M | $24.72 | Nov 3, 2025 | Direct |
| Arcutis Biotherapeutics, Inc. | SVP Chief Financial Officer | Stock Option (right to buy) | 60K | May 6, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ARQT | Arcutis Biotherapeutics, Inc. | Nov 3, 2025 | 1 | -$2.18K | 4 | Nov 5, 2025 | SVP Chief Financial Officer |
| ARQT | Arcutis Biotherapeutics, Inc. | Aug 4, 2025 | 1 | -$1.28K | 4 | Aug 5, 2025 | SVP Chief Financial Officer |
| ARQT | Arcutis Biotherapeutics, Inc. | May 6, 2025 | 2 | $0 | 4 | May 7, 2025 | SVP Chief Financial Officer |
| ARQT | Arcutis Biotherapeutics, Inc. | May 6, 2025 | 0 | $0 | 3 | May 7, 2025 | SVP Chief Financial Officer |